Aspira Womens Health Inc (AWH)
3.40
+0.01
(+0.30%)
USD |
NASDAQ |
Apr 24, 16:00
3.35
-0.05
(-1.47%)
After-Hours: 20:00
Aspira Womens Health Cash from Operations (TTM): -15.89M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -15.89M |
September 30, 2023 | -19.52M |
June 30, 2023 | -23.71M |
March 31, 2023 | -26.60M |
December 31, 2022 | -31.07M |
September 30, 2022 | -31.64M |
June 30, 2022 | -32.13M |
March 31, 2022 | -32.31M |
December 31, 2021 | -27.40M |
September 30, 2021 | -24.50M |
June 30, 2021 | -19.57M |
March 31, 2021 | -16.49M |
December 31, 2020 | -14.73M |
September 30, 2020 | -12.85M |
June 30, 2020 | -13.22M |
March 31, 2020 | -13.36M |
December 31, 2019 | -12.96M |
September 30, 2019 | -12.39M |
June 30, 2019 | -11.24M |
March 31, 2019 | -10.12M |
December 31, 2018 | -9.367M |
September 30, 2018 | -9.221M |
June 30, 2018 | -8.714M |
March 31, 2018 | -8.065M |
December 31, 2017 | -8.129M |
Date | Value |
---|---|
September 30, 2017 | -8.741M |
June 30, 2017 | -9.699M |
March 31, 2017 | -11.39M |
December 31, 2016 | -13.96M |
September 30, 2016 | -15.78M |
June 30, 2016 | -17.35M |
March 31, 2016 | -18.84M |
December 31, 2015 | -18.36M |
September 30, 2015 | -17.99M |
June 30, 2015 | -19.02M |
March 31, 2015 | -17.83M |
December 31, 2014 | -16.81M |
September 30, 2014 | -15.14M |
June 30, 2014 | -11.58M |
March 31, 2014 | -9.556M |
December 31, 2013 | -8.224M |
September 30, 2013 | -8.106M |
June 30, 2013 | -8.336M |
March 31, 2013 | -9.95M |
December 31, 2012 | -10.40M |
September 30, 2012 | -12.72M |
June 30, 2012 | -14.77M |
March 31, 2012 | -15.36M |
December 31, 2011 | -15.58M |
September 30, 2011 | -13.26M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-32.31M
Minimum
Mar 2022
-11.24M
Maximum
Jun 2019
-20.61M
Average
-19.52M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
Bruker Corp | 350.10M |
Azenta Inc | 70.94M |
Harvard Bioscience Inc | 14.03M |
Bionano Genomics Inc | -125.18M |
Akoya Biosciences Inc | -50.90M |